HEAL Toronto Annex
This is an index of miscellaneous articles not indexed on the main pages of the HEAL Toronto web site. These are articles I have come across in my investigations that may be of some interest. What you will find here: debates in the journals about various issues; mainstream articles that if you read between the lines offer evidence for dissident contentions; reports effecting public health policy; articles that have interesting info but suspect agendas (ie; dishing up AIDS dissidence to serve political agendas); things that just annoyed me. - Rob Johnston
KEY QUESTIONS ABOUT HIV
Treatment of AIDS and HIV-Related Conditions: 2001
Prevention of HIV transmission from mother to infant
Interventions aimed at decreasing the risk of mother-to-child transmission of HIV infection (Cochrane Review). The Cochrane Library, Issue 1, 2000. Oxford: Update Software. The drift of this review is certainly tendentious; excluding studies that showed favorable results from vitamin therapy, for instance. The references are useful. Oxidative DNA damage in fetal tissues after transplacental exposure to 3'-azido-3'-deoxythymidine (AZT). Carcinogenesis 2000 May;21(5):1059-1062 Genotoxicity of 3'-azido-3'-deoxythymidine in the human lymphoblastoid cell line, TK6: relationships between DNA incorporation, mutant frequency, and spectrum of deletion mutations in HPRT. Mutat Res 1999 Oct 19;429(2):249-59 Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet. 1999 Sep 25;354(9184):1084-9. more abstracts and citations tracing the history of this "intervention: Zidovudine for the prevention of HIV transmission from mother to infant. MMWR Morb Mortal Wkly Rep. 1994 Apr 29;43(16):285-7. Try this title as a search query at PubMed/Medline. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994 Nov 3;331(18):1173-80. A risk-benefit assessment of zidovudine in the prevention of perinatal HIV transmission. Drug Saf. 1995 Apr;12(4):274-82. Review U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR Morb Mortal Wkly Rep. 1995 Jul 7;44(RR-7):1-15. Prevention of perinatal transmission of human immunodeficiency virus: a progress report 2 years after completion of AIDS Clinical Trials Group trial 076. Clin Infect Dis. 1996 Sep;23(3):438-41. Review. [The reduction of mother-child transmission of HIV infection in developing countries: potential intervention strategies, obstacles to implementation and perspectives. The Reduction of Mother-Child Transmission of HIV Infection in Africa Group]. Sante. 1997 Mar-Apr;7(2):115-25. French. Zidovudine to prevent mother-to-infant HIV transmission in developing countries: any questions? Van der Stuyft P, Boelaert M, Temmerman M. Trop Med Int Health. 1998 Sep;3(9):689-90. No abstract available. Preventing transmission of HIV from mother to child--is South Africa ready and willing? Wilkinson D, McIntyre J. S Afr Med J. 1998 Oct;88(10):1304-6. No abstract available. The mother-to-child HIV transmission debate. [various authors] S Afr Med J. 1999 Feb;89(2) No abstract available. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies. The International Perinatal HIV Group. N Engl J Med. 1999 Apr 1;340(13):977-87. The effects of zidovudine in the subset of infants infected with human immunodeficiency virus type-1 (Pediatric AIDS Clinical Trials Group Protocol 076). J Pediatr. 1999 Jun;134(6):717-24. Zidovudine to prevent mother-to-infant HIV transmission in developing countries: a view from Thailand. Kumphitak A, Cawthorne P, Lakhonphol S, Kasi-Sedapan S, Sanaeha S, Unchit N, Wilson D. Trop Med Int Health. 1999 Mar;4(3):236-7; discussion 237-8. No abstract available. For the latest citations search "Zidovudine for the prevention of HIV transmission" at PubMed/Medline. (If you search "AZT" over 6000 citations come up!) ***
Survival after introduction of HAART in people with known duration of HIV-1 infection The CASCADE Collaboration The Lancet; London; Apr 1, 2000 CMAJ on Routine Prenatal HIV Screening
Evidence-based guidelines for universal counselling
and offering of HIV testing in pregnancy in Canada
Access to prenatal HIV testing
***
False-positive HIV Test: Implications for the Patient. [Letters] JAMA, Volume 269(22).Jun 9, 1993.2847
Relation Of The Course Of HIV Infection In Children To The Severity Of The Disease In Their
Mothers At Delivery.
[Original Article]
AIDS CASES TO DOUBLE (With the Deft Stroke of a Bureaucrat's Pen)
Scaring Us Toward Global Government
Surrogate Markers in AIDS Research: Is There Truth in Numbers? [Controversies]
Controversies: Does the CD4+ Cell Count Reflect Clinical Efficacy? [Letters: In Reply]
Surrogate End Points in Clinical Trials: Are We Being Misled?
Preliminary analysis of the Concorde trial. [Letters to the Editor]
Misdiagnosis of HIV Infection by HIV-1 Plasma Viral Load Testing: A Case Series [Brief Communications]
HIV Testing in Pregnant Women [Letters]
1. Nakchbandi IA, Longenecker JC, Ricksecker MA, Latta RA, Healton C, Smith DG. A decision analysis of mandatory compared with voluntary HIV testing in pregnant women. Ann Intern Med. 1998;128:760-7.Antiretroviral Therapy For Adult HIV-Infected Patients: Recommendations From a State-of-the-Art Conference [Special Communication] Sande: JAMA, Volume 270(21).Dec 1, 1993.pp 2583-2589.
The 1987 Revision of the CDC Surveillance Case Definition for Acquired Immunodeficiency Syndrome
Differential Survival of Patients With AIDS According to the 1987 and 1993 CDC Case Definitions[Brief Report]
Influence of infant-feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: a prospective cohort study [Early Reports]
Infant feeding and HIV-1 transmission [Commentary]  TORONTO
tel/fax:(416) 406-HEAL
INDEX
Search our web site (400+ pages)
|
